Optigenex Inc. announced the results of a pilot study entitled A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of AlphaBrain(TM) administered orally, conducted by the Boston Center for Memory. The purpose of the study was to test the efficacy of AlphaBrain(TM) with ac-11(R) as an enhancer of cognitive ability, including memory, attention, problem solving and reasoning. Developed by Optigenex, AC-11(R) is a patented, all natural rain forest botanical extract shown to help the body's natural ability to repair damaged DNA.

The Onnit-sponsored study, which utilized a methodology and study design similar to that applied in new drug evaluations, but not often used in research to evaluate dietary supplements, demonstrated statistically significant improvements in areas related to memory and "executive function" (e.g., reasoning and problem solving) among the test subject volunteers taking AlphaBrain(TM) with ac-11(R).